Final results for the 1703 phase 1b/2 study of Elotuzumab in combination with Lenalidomide and Dexamethasone in patients with relapsed/refractory multiple myeloma

Saved in:
Bibliographic Details
Other Authors: Richardson, Paul G. (Other) , Raab, Marc-Steffen (Other)
Format: Article (Journal) Conference Paper
Language:English
Published: 2014
In: Blood
Year: 2014, Volume: 124, Issue: 21
ISSN:1528-0020
Subjects:
Online Access:Verlag, kostenfrei, Volltext: https://ashpublications.org/blood/article/124/21/302/96592/Final-Results-for-the-1703-Phase-1b-2-Study-of
Get full text
Author Notes:Paul G. Richardson, Sundar Jagannath, Philippe Moreau, Andrzej Jakubowiak, Marc S. Raab, Thierry Facon, Ravi Vij, Darrell White, Donna E. Reece, Lotfi Benboubker, Jeffrey Zonder, L. Claire Tsao, Kenneth C. Anderson, Eric Bleickardt, Anil K. Singhal, Sagar Lonial
Description
Item Description:Gesehen am 09.07.2015
Physical Description:Online Resource
ISSN:1528-0020